| Product NDC: | 0187-2201 |
| Proprietary Name: | CeraVe |
| Non Proprietary Name: | Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide |
| Active Ingredient(s): | 3.5; 3.5; 3.5; 1.75; 16.56 g/70g; g/70g; g/70g; g/70g; g/70g & nbsp; Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0187-2201 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20120827 |
| Package NDC: | 0187-2201-01 |
| Package Description: | 70 g in 1 TUBE (0187-2201-01) |
| NDC Code | 0187-2201-01 |
| Proprietary Name | CeraVe |
| Package Description | 70 g in 1 TUBE (0187-2201-01) |
| Product NDC | 0187-2201 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Homosalate, Meradimate, Octinoxate, Titanium Dioxide, and Zinc Oxide |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20120827 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | HOMOSALATE; MERADIMATE; OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE |
| Strength Number | 3.5; 3.5; 3.5; 1.75; 16.56 |
| Strength Unit | g/70g; g/70g; g/70g; g/70g; g/70g |
| Pharmaceutical Classes |